drugset / Trial / NCT02605707

Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke

NCT02605707 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.Stem cell transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous endothelial progenitor cells in patients with chronic stroke.

Timeline

Start
2014-11
Primary completion
2017-12
Completion
2020-02

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous endothelial progenitor cells Unknown — Intravenous

Indications